Brain metastases in patients receiving trastuzumab for breast cancer.
Errante
D
D
Bernardi
D
D
Bianco
A
A
Salvagno
L
L
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000209:etiology / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000209:etiology / Q000556:secondary*; D005260:Female; D006801:Humans; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab